Polatuzumab Vedotin, Zanubrutinib and Rituximab Achieved Rapid and Deep Response in Previously Untreated Frail and Elderly Diffuse Large B-Cell Lymphoma Patients

被引：0
|
作者：
Ren, Yuhong [1 ]
Zhuang, Jingli [2 ]
Yuan, Ling [2 ]
Ji, Lili [1 ]
Ke, Yang [1 ]
Liu, Peng [3 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Hematol, Shanghai, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Hematol, Shanghai, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-186170
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
    Tilly, Herve
    Morschhauser, Franck
    Sehn, Laurie H.
    Friedberg, Jonathan W.
    Trneny, M.
    Sharman, Jeff P.
    Herbaux, Charles
    Burke, John M.
    Matasar, Matthew
    Rai, Shinya
    Izutsu, Koji
    Mehta-Shah, Neha
    Oberic, Lucie
    Chauchet, Adrien
    Jurczak, Wojciech
    Song, Yuqin
    Greil, Richard
    Mykhalska, Larysa
    Bergua-Burgues, Juan M.
    Cheung, Matthew C.
    Pinto, Antonio
    Shin, Ho-Jin
    Hapgood, Greg
    Munhoz, Eduardo
    Abrisqueta, Pau
    Gau, Jyh-Pyng
    Hirata, Jamie
    Jiang, Yanwen
    Yan, Mark
    Lee, Calvin
    Flowers, Christopher R.
    Salles, Gilles
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04): : 351 - 363
  • [2] Mosunetuzumab and Polatuzumab Vedotin Demonstrates Preliminary Efficacy in Elderly Unfit/Frail Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
    Olszewski, Adam J.
    Eradat, Herbert
    Avigdor, Abraham
    Horowitz, Netanel A.
    Babu, Sunil
    Levi, Itai
    McKinney, Matthew
    Lee, Seung Tae
    Bergua Burgues, Juan Miguel
    Rodriguez Izquierdo, Antonia
    Bastos-Oreiro, Mariana
    Ganzel, Chezi
    Kim, Tae Min
    Jeon, Youngwoo
    Taszner, Michal
    Narkhede, Mayur
    Kim, Won Seog
    Shin, Ho-Jin
    Lavie, David
    Woszczyk, Dariusz
    Dunshee, Diana
    Kapp, Amy V.
    Zhou, Mingzhu
    Batlevi, Connie Lee
    Ead, Wahib
    Sellam, Gila
    Jurczak, Wojciech
    BLOOD, 2023, 142
  • [3] Cost-Effectiveness of Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
    Matasar, Matthew
    Masaquel, Anthony
    Rodrigo, Ho
    Launonen, Aino
    Ng, Carmen
    Wang, Rongrong
    Fox, David
    Hossain, Farah
    Li, Jia
    Roth, Joshua A.
    Burke, John M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S359 - S360
  • [4] Zanubrutinib, Polatuzumab Vedotin and Rituximab (ZPR) Combination Regimen for Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma
    Zhang, Yian
    Yuan, Ling
    Zhuang, Jingli
    Wang, Zhimei
    Zhang, Xuejiao
    Wang, Weiguang
    Liu, Peng
    BLOOD, 2023, 142
  • [5] New European approval: Polatuzumab vedotin associated to rituximab, cyclophosphamide, doxorubicin and prednisone in previously untreated Diffuse Large B-Cell Lymphoma
    Turot, Melanie
    Requena, Gaspar Aspas
    BULLETIN DU CANCER, 2022, 109 (12) : 1234 - 1235
  • [6] Zanubrutinib Plus Rituximab for the Treatment of Elderly Unfit Patients with Previously Untreated Diffuse Large-B Cell Lymphoma
    Bai, Jiefei
    Li, Jiangtao
    Feng, Ru
    Qian, Long
    Yin, Jingjing
    Zhang, Shuai
    Wang, Ting
    Yang, Yazi
    Zhang, Chunli
    Li, Jian
    Liu, Hui
    BLOOD, 2022, 140 : 3748 - 3749
  • [7] US cost-effectiveness analysis of polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma
    Matasar, Matthew
    Masaquel, Anthony
    S. Ho, Rodrigo
    Launonen, Aino
    Ng, Carmen D.
    Wang, Rongrong
    Fox, David
    Hossain, Farah
    Li, Jia
    Burke, John M.
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1134 - 1144
  • [8] POLA-R-CHP: POLATUZUMAB VEDOTIN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE FOR PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA
    Tilly, H.
    Sharman, J.
    Bartlett, N.
    Morschhauser, F.
    Haioun, C.
    Munoz, J.
    Chen, A.
    Lamy, T.
    Wang, L.
    Penuel, E.
    Hirata, J.
    Lee, C.
    Salles, G.
    HAEMATOLOGICA, 2017, 102 : 4 - 4
  • [9] EFFICACY AND SAFETY OF RITUXIMAB, BENDAMUSTINE AND DEXAMETHASONE AS INDUCTION THERAPY IN FRAIL ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA
    Pezzullo, L.
    Bruno, A.
    Cassiodoro, G.
    Bianco, R.
    Villani, G.
    Rosamilio, R.
    Martorelli, M.
    Fontana, R.
    Guariglia, R.
    Serio, B.
    Selleri, C.
    HAEMATOLOGICA, 2019, 104 : 170 - 170
  • [10] An evaluation of polatuzumab vedotin for the treatment of patients with diffuse large B-cell lymphoma
    Walji, Moneeza
    Assouline, Sarit
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 933 - 942
12345